By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Asterias Biotherapeutics 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-433-2992 Fax: n/a



Company News
Asterias Biotherapeutics Receives $11.7 Million In Proceeds From Exercise Of Warrants 5/26/2015 7:33:50 AM
Asterias Biotherapeutics Announces Availability Of Abstract With Phase 2 Clinical Data On Cancer Vaccine AST-VAC1 In Acute Myelogenous Leukemia (AML) 5/14/2015 6:22:22 AM
Asterias Biotherapeutics Reports First Quarter Results 5/8/2015 6:39:40 AM
Asterias Biotherapeutics Promotes Edward Wirth, M.D., Ph.D. To Chief Medical Officer 5/8/2015 6:20:29 AM
Asterias Biotherapeutics To Host Investor Meeting To Review Clinical Development Strategy For AST-OPC1 In Spinal Cord Injury 5/7/2015 7:58:33 AM
Asterias Biotherapeutics To Report First Quarter Results On May 7, 2015 4/30/2015 6:56:41 AM
Asterias Biotherapeutics Announces Phase 2 Clinical Data On Autologous Telomerase-Based Dendritic Cell Cancer Vaccine AST-VAC1 Selected For Oral Presentation At The 2015 ASCO Annual Meeting 4/22/2015 10:30:19 AM
Asterias Biotherapeutics Announces Change To Presentation Time At Needham Healthcare Conference 4/9/2015 6:55:01 AM
Asterias Biotherapeutics To Present At Needham Healthcare Conference 4/6/2015 8:20:43 AM
Asterias Biotherapeutics To Present At Regen Med Investor Day 2015 3/18/2015 9:36:45 AM